NCT06469983

Brief Summary

In the rehabilitation project for patients with severe Acquired Brain Injury (sABI), it is essential to include exercises that facilitate the recovery of the upright position (or verticalization). Recently, tilt-table equipped with the robot-assisted lower limbs cyclic mobilization has been proposed as a safe and suitable device for accelerating the adaptation to vertical posture in bedridden patients with brain-injury since the acute phase. The present multicentre study aims at evaluating the effectiveness of robotic assisted verticalization plus mobilization (VEM) versus traditional verticalization (TV) in a large cohort of patients with sABI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Dec 2024Nov 2026

First Submitted

Initial submission to the registry

June 14, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

1.6 years

First QC Date

June 14, 2024

Last Update Submit

November 17, 2025

Conditions

Keywords

Disorders of Consciousnessrehabilitationverticalizationrobotic

Outcome Measures

Primary Outcomes (1)

  • Levels of cognitive functioning

    A clinical scale assessing global cognitive functioning in patients emerged from a disorder of consciousness. Higher scores indicate a higher cognitive functioning

    5 weeks

Secondary Outcomes (5)

  • Modified Ashworth scale

    5 weeks - 1 month after treatment

  • Medical Research Council Scale

    5 weeks - 1 month after treatment

  • modified Barthel Index

    5 weeks - 1 month after treatment

  • Disability Rating Scale

    5 weeks - 1 month after treatment

  • System Usability Scale

    5 weeks - 1 month after treatment

Other Outcomes (9)

  • Spectral metrics

    5 weeks - 1 month after treatment

  • Microstate metrics

    5 weeks - 1 month after treatment

  • Connectivity metrics

    5 weeks - 1 month after treatment

  • +6 more other outcomes

Study Arms (2)

Robotic Verticalization

EXPERIMENTAL

Erigo® gradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance. The Erigo verticalization is coupled with the rhythmic passive movement of the lower limbs ensuring the more normal range of motion (ROM) and the alternation of loading and unloading of the lower limbs, based on patient's osteo-articular condition (e.g., ROM=45°; cadence=min. 24 steps per minute).

Device: ErigoBasic or ErigoPro®

Traditional Verticalization

ACTIVE COMPARATOR

gradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance, using a traditional standing device (i.e., non-robotic traditional tilt table)

Behavioral: Traditional Verticalization

Interventions

Static bed with integrated robotic stepper (ErigoBasic) and optionally integrated with Functional Electrical Stimulation (FES ErigoPro®). The Erigo is a robot designed to be used for early functional mobilisation of patients with neurological manifestations or who are bedridden, even in intensive care. It is a tilt table equipped with an integrated passive stepper controlled by microprocessors that generate physiological leg movements: the patient's thighs are secured by straps to the movement mechanisms and the feet are secured to plates equipped with shock absorbers, while the upper body is held in place by a sling integrated into the table. Erigo provides active functions: gradual elevation in orthostatism up to 90°, controlled and independent mobilisation of the lower limbs, and functional stimulation.

Robotic Verticalization

gradual verticalization (from supine position up to maximum 90°, in 3 steps), depending on the patient's vital signs compliance, using a traditional standing device (i.e., non-robotic traditional tilt table)

Traditional Verticalization

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 75 years;
  • sABI due to traumatic, vascular, anoxic, or mixed etiology;
  • Stable behavioral/cognitive diagnosis on at least 4 behavioral evaluations in 1 week using the Italian version of the CRS-R in patients with pDoC, or the LCF-based cognitive assessment in patients with eDoC;
  • Time post-injury between 28 days and 6 months \[1\];
  • Not recovered upright station;
  • Written informed consent by the patient's legal rep-resentative/primary caregiver.

You may not qualify if:

  • Severe medical conditions hampering verticalization (e.g., severe hypotension or conditions realizing hemodynamic instability, end stage or severe symptomatic heart failure with reduced ejection fraction, cardiac arrhythmia of new diagnosis or arrhythmic flare, severe hepatic failure, chronic severe lower limb arterio-venous disease, sep-sis/septic shock, thrombus venous embolism of new diag-nosis, severe autonomic dysreflexia);
  • Severe medical conditions hampering lower limb mobili-zation (e.g., fractures, heterotopic ossifications);
  • Severe medical conditions impacting EEG activity (e.g., sub-continuous or abundant EEG epileptiform abnormali-ties);
  • Severe medical conditions influencing conscious-ness/cognitive status, such as severe hyponatremia or hy-poglycemia;
  • Contraindications to the use of Erigo®Basic and/or Eri-go®Pro (Hocoma, Volketswil, Switzerland) as per technical data sheet (see Appendix A);
  • Presence of prohibited drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Polo Specialistico Riabilitativo Fondazione Don Carlo Gnocchi ONLUS

Sant'Angelo dei Lombardi, Avellino, 83054, Italy

RECRUITING

IRCCS Maugeri Telese Terme

Telese Terme, BN, 82037, Italy

RECRUITING

IRCCS "S. Maria Nascente" - Fondazione Don Gnocchi

Milan, Milan, 20148, Italy

RECRUITING

IRCCS Maugeri Bari

Bari, 70124, Italy

RECRUITING

Ospedale Policlinico San Martino

Genova, 16132, Italy

RECRUITING

ICS Maugeri

Pavia, 27100, Italy

RECRUITING

MeSH Terms

Conditions

Brain InjuriesConsciousness Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Double blind could not be applicable since a physical therapist could be blinded due to the nature of the intervention (VEM or SV). However, clinical evaluation will be performed by an examiner blind to the patient' group of treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior Researcher

Study Record Dates

First Submitted

June 14, 2024

First Posted

June 24, 2024

Study Start

December 2, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

November 20, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

A plan for wide dissemination of the results will be activated at the beginning, during and at the end of the project, through presentations at national and international conferences, and newsletters of scientific societies in the rehabilitation, neurological, and neuropsychological fields, to ensure that the results are shared with the scientific community. At the end of the project, the analysed results will be the subject of scientific publications in national and international peer-reviewed journals. The project will also be presented at regular conferences involving stakeholders (clinicians, patient and family associations) in accordance with the dissemination plan of the pnrr Fit4Med project.

Locations